COMBINATION OF AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE: IS IT POSSIBLE TO FIGHT SYSTEMIC HYPERTENSION AND OBESITY TOGETHER?

COMBINATION OF AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE: IS IT POSSIBLE TO FIGHT SYSTEMIC HYPERTENSION AND OBESITY TOGETHER?

Arterial hypertension (AH) and obesity are the main risk factors of chronic noncommunicable diseases. Adipous tissue is not only a depot for energetic compounds, but is an active endocrine organ synthetizing biologically active substances that facilitate development of AH. Patients with AH and obesi...

Full description

Bibliographic Details
Main Authors:	Yu. A. Vasyuk, E. Yu. Shupenina, E. A. Nesterova, E. I. Golubkova, V. V. Nesvetov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2017-10-01
Series:	Российский кардиологический журнал
Subjects:	arterial hypertension obesity aortic stiffness diastolic dysfunction exercise tolerance
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2512

Similar Items

A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone
by: Michael A Weber, et al.
Published: (2018-09-01)

Comparative analysis of antihypertensive effects of chlorthalidone and indapamide-retard in combination with azilsartan medoxomil in patients with arterial hypertension
by: Zh. D. Kobalava, et al.
Published: (2019-07-01)

Correspondence between Aortic and Arterial Stiffness, and Diastolic Dysfunction in Apparently Healthy Female Patients with Post-Acute COVID-19 Syndrome
by: Cristina Tudoran, et al.
Published: (2023-02-01)

Full spectrum and genetic algorithm-selected spectrum-based chemometric methods for simultaneous determination of azilsartan medoxomil, chlorthalidone, and azilsartan: Development, validation, and application on commercial dosage form
by: Darwish Hany W., et al.
Published: (2021-03-01)

Altered diastolic function and aortic stiffness in Alzheimer’s disease
by: Çalık AN, et al.
Published: (2014-07-01)

Comparative Efficacy of Single Pill Combinations of Azilsartan Medoxomil/Chlorthalidone and Losartan/Hydrochlorothiazide in Patients with Hypertension and Heart Failure with Preserved Ejection Fraction
by: Zh. D. Kobalava, et al.
Published: (2022-05-01)

Heart Failure and Aortic Stiffening in Patients with Preserved Ejection Fraction
by: Barış Şensoy, et al.
Published: (2021-07-01)

MODERN OPPORTUNITIES FOR ANTIHYPERTENSION THERAPY: THE PLACE OF AZILSARTAN MEDOXOMIL
by: V. V. Skibitsky, et al.
Published: (2017-12-01)

Relations of Central Hemodynamics and Aortic Stiffness with Left Ventricular Structure and Function: The Framingham Heart Study
by: Bernhard M. Kaess, et al.
Published: (2016-03-01)

Azilsartan/chlorthalidone combination therapy for blood pressure control
by: Cheng JW
Published: (2013-05-01)

Diastolic versus Systolic Left Ventricular Dysfunction as Independent Predictors for Unfavorable Postoperative Evolution in Patients with Aortic Regurgitation Undergoing Aortic Valve Replacement
by: Luminita Iliuta, et al.
Published: (2022-11-01)

BRAIN NATRIURETIC PEPTIDE AS BIOCHEMICAL MARKER FOR STRUCTURAL AND FUNCTIONAL HEART DISORDERS IN ARTERIAL HYPERTENSION
by: S. V. Ivanova, et al.
Published: (2015-12-01)

Increased Stiffness Is the Major Early Abnormality in a Pig Model of Severe Aortic Stenosis and Predisposes to Congestive Heart Failure in the Absence of Systolic Dysfunction
by: Kiyotake Ishikawa, et al.
Published: (2015-05-01)

Efficacy and safety of azilsartan medoxomil in various doses in patients with metabolic disorders
by: Nikita B. Perepech, et al.
Published: (2021-10-01)

Fructose plus High-Salt Diet in Early Life Results in Salt-Sensitive Cardiovascular Changes in Mature Male Sprague Dawley Rats
by: Peter E. Levanovich, et al.
Published: (2021-09-01)

Incidence and Risk Factors for Long-Term Persistence of Diastolic Dysfunction after Aortic Valve Replacement for Aortic Stenosis Compared with Aortic Regurgitation
by: Luminița Iliuță, et al.
Published: (2023-03-01)

Azilsartan, but not Candesartan Improves Left Ventricular Diastolic Function in Patients with Hypertension and Heart Failure
by: Mari Sakamoto, et al.
Published: (2015-12-01)

Relation of elastic properties of pulmonary artery with left ventricular abnormalities and aortic stiffness in patients with moderate to severe obstructive sleep apnea: A cross-sectional echocardiographic study
by: İbrahim Halil Altıparmak, et al.
Published: (2016-06-01)

Increased Arterial Stiffness Is Associated With Reduced Diastolic Function in Youth With Obesity and Type 2 Diabetes
by: Nicolas L. Madsen, et al.
Published: (2021-11-01)

Linear and volumetric parameters of left atrium in patients with isolated aortic stenosis
by: G. E. Gendlin, et al.
Published: (2019-11-01)

Clinical utility of azilsartan&ndash;chlorthalidone fixed combination in the management of hypertension
by: Shuster JE, et al.
Published: (2012-06-01)

Azilsartan medoxomil for improving insulin resistance and adipokine levels in hypertension in comparison with angiotensin-converting enzyme inhibitors
by: S. V. Nedogoda, et al.
Published: (2020-08-01)

Cross‐Sectional Relationships of Proximal Aortic Stiffness and Left Ventricular Diastolic Function in Adults in the Community
by: Nicholas Spetko, et al.
Published: (2022-12-01)

Advantages azilsartan medoxomil in patients with arterial hypertension: how to make a choice and to optimize antihypertensive therapy?
by: T V Martynyuk, et al.
Published: (2017-06-01)

Advantages azilsartan medoxomil in patients with arterial hypertension: how to make a choice and to optimize antihypertensive therapy?
by: Martynyuk T.V., et al.
Published: (2017-05-01)

New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil
by: Volpe M, et al.
Published: (2012-03-01)

THE ROLE OF FACTORS AFFECTING THE FORMATION OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION
by: M. V. Kurkina, et al.
Published: (2017-11-01)

Left Atrial Phasic Function in Patients with Hypertension and Recurrent Atrial Fibrillation: Gender Differences of the Relationship with Diastolic Dysfunction and Central Aortic Pressure
by: E. V. Kokhan, et al.
Published: (2019-11-01)

Diastolic Dysfunction and Health Status Outcomes After Transcatheter Aortic Valve Replacement
by: Rayan S. El-Zein, DO, et al.
Published: (2024-01-01)

Experts of RMSAH opinion: the fixed combination of azilsartan medoxomil and chlortalidone is broadening options of the combined therapyin patients with arterial hypertension
by: I E Chazova, et al.
Published: (2015-09-01)

The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus
by: Juliya V Zhernakova, et al.
Published: (2019-09-01)

The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders
by: Yu V Zhernakov, et al.
Published: (2014-12-01)

Arterial stiffness as a factor of structural and functional cardiac remodeling in obesity
by: M. A. Druzhilov, et al.
Published: (2020-06-01)

ATRIAL FIBRILLATION AND ARTERIAL HYPERTENSION: GENDER DIFFERENCES OF VENTRICULOATRIAL REMODELING WITH PRESERVED EJECTION FRACTION
by: Zh. D. Kobalava, et al.
Published: (2017-09-01)

Presystolic flow in ascending aorta in a case of left ventricular diastolic dysfunction
by: S.R. Mittal
Published: (2015-03-01)

Efficacy and safety of azilsartan medoxomil and telmisartan in hypertensive patients: A randomized, assessor-blinded study
by: Megha Garg, et al.
Published: (2020-01-01)

Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension
by: Attila Juhasz, et al.
Published: (2018-02-01)

Clinical Efficacy of Combined Use of Azilsartan with Indapamide and Azilsartan with Nitrendipine in Patients with Arterial Hypertension
by: Z. T. Mashkurova, et al.
Published: (2022-09-01)

Aortic Stiffness and Pulsatile Pressures as Potential Mediators of Chronic Kidney Disease Induced Impaired Diastolic Function
by: Hsu HC, et al.
Published: (2022-02-01)

Additional Prognostic Value of Tissue Doppler Evaluation in Patients with Aortic Stenosis and Left-Ventricular Systolic Dysfunction Undergoing Aortic Valve Replacement
by: Luminita Iliuta, et al.
Published: (2022-10-01)